Developer docs
API playgroundTry for free, no card

Search company profiles

Two Bear Capital

Full company profile

uuid00002a5

Namestring
Two Bear Capital
Legal namestring
Two Bear Capital
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Two Bear Capital is a private venture capital firm founded in 2019 by Mike Goguen, a 20-year veteran of Sequoia Capital who sponsored 54 investments with combined market value exceeding $67B. The firm invests in early-stage technology and life sciences companies headquartered in the United States or Canada, typically leading or co-leading Seed through Series B rounds with initial checks of $3-10M. Its investment thesis concentrates on five disruptive sectors — biotechnology, bioinformatics, healthcare IT, machine learning and AI, and information security — with active board participation across the portfolio.

The firm is staffed by investors, operators, and advisors with deep domain expertise spanning technology and life sciences, including multiple PhD-trained partners and access to Nobel Laureate James Allison as an advisor. It maintains offices in Whitefish (Montana headquarters), Menlo Park, San Diego, Boston, and New York, covering the major US innovation corridors. The portfolio of 23+ companies includes QuSecure (post-quantum cryptography), Selector (AI-powered network observability, valued at $375M in February 2026), Conceal (browser-native SSE/ZTNA), Rainfall Health (AI hospital compliance), Gravwell (data analytics), Binarly (firmware supply chain security), Leapfrog Bio (precision oncology), and TileDB (data infrastructure).

The business operates on standard venture capital economics: management fees charged to limited partners (typically ~2% of committed capital) plus carried interest (typically 20%) on successful exits. The firm supplements direct investment with active portfolio support through dedicated platform, operations, capital formation, and CIO functions, and sources deals through founder networks, direct outreach, co-investor syndicates, and a public pitch portal. Two Bear Capital's owner-operator identity is reinforced by Mike Goguen's Montana-based community engagement, including his role as a first responder with Two Bear Air rescue operations.

Short descriptiontext

Two Bear Capital is a Whitefish, Montana-based venture capital firm founded in 2019 that invests Seed through Series B in early-stage technology and life sciences companies across the US and Canada with $3-10M initial checks. The firm is led by Mike Goguen and focuses on biotechnology, bioinformatics, healthcare IT, AI, and cybersecurity.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWhitefish, United States
HQ citystring
Whitefish
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investing, early-stage technology investments, life sciences venture funding, seed and series A funding, biotechnology investments
Industry2 codes
1Early-Stage Venture Capital (Series A/B)
CodeFSANAAABPrimaryYes
2Sector-Focused Venture Capital (Vertical Specialists)
CodeFSANAAADPrimaryNo
NAICS code2 codes
  • Portfolio Management and Investment Advice52394
  • Securities, Commodity Contracts, and Other Financial Investments and Related Activities523
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Management Fees
TypeSubscription Recurring
Description

Standard VC fund management fees charged to limited partners, typically 2% of committed capital during the investment period.

twobearcapital.com
2Carried Interest
TypeTransaction Fee
Description

Performance-based carry (typically 20%) from successful portfolio company exits, representing the primary economic upside for the GP team.

twobearcapital.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
Pricing details1 tier
1VC fund management with 2% management fee and 20% carried interest (industry standard)
ModelSubscriptionBilling cadenceAnnual
Notes

Standard VC fund economics - 2% management fee on committed capital, 20% carry on profits above the hurdle rate. Fund lifecycle typically 10 years with possible extensions.

twobearcapital.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Two Bear Capital is a private venture capital firm that invests in early-stage (Seed to Series B) technology and life sciences companies headquartered in the US and Canada. The firm typically leads or co-leads funding rounds with initial checks of $3-10M, providing portfolio companies with strategic guidance, operational support, network access, and active board participation across five focus sectors: Biotechnology, Bioinformatics, Healthcare IT, Machine learning & AI, and Information security.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • $67B+ combined market value from 54 investments at Sequoia
+1 more record
Product overview1 text field

Two Bear Capital is a venture capital firm, not a product company. It does not offer a unified product platform or software-as-a-service offering. The firm invests in founders building companies at the intersection of life sciences and technology, providing early-stage capital and mentorship to portfolio companies. Two Bear Capital's focus areas include biotechnology, bioinformatics, healthcare IT, machine learning & AI, and information security. The firm's activities are centered on investment management, portfolio company support, and capital formation rather than product development or commercialization.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

QuProtect platform is available for purchase through AWS Marketplace, making it accessible to AWS customers seeking post-quantum cryptography solutions.

Strategic tierModerateTypeChannel Partner/ Reseller/ Distributor
Description

QuSecure's QuProtect platform is available through Dell's sales channel.

Strategic tierModerateTypeChannel Partner/ Reseller/ Distributor
Description

QuSecure's QuProtect platform is available through Cisco's sales channel.

Strategic tierModerateTypeChannel Partner/ Reseller/ Distributor
Description

QuSecure's QuProtect platform is available through Carahsoft for government customers.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

FYR Bio and NuvOx Therapeutics were jointly awarded an NCI Direct-to-Phase-II SBIR Grant to advance liquid-biopsy collaboration in a Phase IIb glioblastoma trial.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Early-stage venture firm investing at the intersection of science and technology, with a similar thesis around biotech, AI, and frontier-tech bets. Directly comparable in check size, sector focus, and stage (Seed to Series B) to Two Bear Capital.

TypeDirect peer
Description

Early-stage venture firm heavily focused on life sciences, biotech, and deep-tech companies out of university and research labs. Highly comparable to Two Bear Capital's biotech and bioinformatics emphasis, including Nobel-tier scientific advisors.

TypeDirect peer
Description

Early-stage venture firm investing across technology and life sciences with high-conviction, founder-led approach. Directly comparable in sector breadth (AI, biotech, cybersecurity) and willingness to lead Seed/Series A rounds.

TypeDirect peer
Description

Science- and engineering-led venture firm investing in early-stage companies at the intersection of deep tech, AI, and life sciences. Closely comparable thesis and stage focus to Two Bear Capital.

TypeDirect peer
Description

Early-stage venture firm focused on transformative technologies across biotech, AI, and frontier software. Comparable in founder-pedigree-driven brand, willingness to lead rounds, and high-conviction sector bets.

TypeDirect peer
Description

Early-stage venture firm investing in technology, life sciences, and logistics with an operator-heavy team. Comparable in check size, sector breadth, and emphasis on operational support to founders.

TypeDirect peer
Description

Venture firm investing in early-stage companies at the intersection of technology and healthcare/life sciences. Highly comparable thesis given Two Bear Capital's biotech and healthcare IT focus, and similar fund scale.

TypeBroad incumbent
Description

Multi-stage venture firm with broad sector coverage including life sciences, security, and AI. Larger and more diversified than Two Bear Capital but invests in overlapping categories and at comparable early stages.

TypeBroad incumbent
Description

Mega-fund venture firm with dedicated bio/health and security practices. Operates at significantly larger fund scale than Two Bear Capital but overlaps heavily in thesis areas like AI, cybersecurity, and biotech.

TypeBroad incumbent
Description

Large multi-stage venture firm with deep life sciences and technology franchises. Comparable in sector breadth but materially larger fund size, providing context for Two Bear Capital's relative scale within the early-stage VC landscape.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment35 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Two Bear Capital

Venture Capitaltwobearcapital.com

Two Bear Capital is a Whitefish, Montana-based venture capital firm founded in 2019 that invests Seed through Series B in early-stage technology and life sciences companies across the US and Canada with $3-10M initial checks. The firm is led by Mike Goguen and focuses on biotechnology, bioinformatics, healthcare IT, AI, and cybersecurity.

What Two Bear Capital does

Two Bear Capital is a private venture capital firm founded in 2019 by Mike Goguen, a 20-year veteran of Sequoia Capital who sponsored 54 investments with combined market value exceeding $67B. The firm invests in early-stage technology and life sciences companies headquartered in the United States or Canada, typically leading or co-leading Seed through Series B rounds with initial checks of $3-10M. Its investment thesis concentrates on five disruptive sectors — biotechnology, bioinformatics, healthcare IT, machine learning and AI, and information security — with active board participation across the portfolio.

The firm is staffed by investors, operators, and advisors with deep domain expertise spanning technology and life sciences, including multiple PhD-trained partners and access to Nobel Laureate James Allison as an advisor. It maintains offices in Whitefish (Montana headquarters), Menlo Park, San Diego, Boston, and New York, covering the major US innovation corridors. The portfolio of 23+ companies includes QuSecure (post-quantum cryptography), Selector (AI-powered network observability, valued at $375M in February 2026), Conceal (browser-native SSE/ZTNA), Rainfall Health (AI hospital compliance), Gravwell (data analytics), Binarly (firmware supply chain security), Leapfrog Bio (precision oncology), and TileDB (data infrastructure).

The business operates on standard venture capital economics: management fees charged to limited partners (typically ~2% of committed capital) plus carried interest (typically 20%) on successful exits. The firm supplements direct investment with active portfolio support through dedicated platform, operations, capital formation, and CIO functions, and sources deals through founder networks, direct outreach, co-investor syndicates, and a public pitch portal. Two Bear Capital's owner-operator identity is reinforced by Mike Goguen's Montana-based community engagement, including his role as a first responder with Two Bear Air rescue operations.

Two Bear Capital firmographics

Firmographics
Name
Two Bear Capital
Legal name
Two Bear Capital
Website
https://twobearcapital.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Two Bear Capital is a Whitefish, Montana-based venture capital firm founded in 2019 that invests Seed through Series B in early-stage technology and life sciences companies across the US and Canada with $3-10M initial checks. The firm is led by Mike Goguen and focuses on biotechnology, bioinformatics, healthcare IT, AI, and cybersecurity.
Ownership category
akta.pro rank

Two Bear Capital industry classification

Industry
Product category
Venture Capital
NAICS
Portfolio Management and Investment Advice (52394), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)
SIC
Investment Advice (6282)
akta.pro primary industry
Early-Stage Venture Capital (Series A/B) (FSANAAAB)
akta.pro secondary industry
Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

  • Venture capital investing
  • Early-stage technology investments
  • Life sciences venture funding
  • Seed and series A funding
  • Biotechnology investments

Where Two Bear Capital is headquartered

Location

Headquarters

HQ city
Whitefish
HQ country
United States
HQ region
North America

Offices5 records

Markets served

Two Bear Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Management Fees: Standard VC fund management fees charged to limited partners, typically 2% of committed capital during the investment period.
  2. Carried Interest: Performance-based carry (typically 20%) from successful portfolio company exits, representing the primary economic upside for the GP team.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualVC fund management with 2% management fee and 20% carried interest (industry standard)

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Two Bear Capital product offering

Product offering

Core offering

Two Bear Capital is a private venture capital firm that invests in early-stage (Seed to Series B) technology and life sciences companies headquartered in the US and Canada. The firm typically leads or co-leads funding rounds with initial checks of $3-10M, providing portfolio companies with strategic guidance, operational support, network access, and active board participation across five focus sectors: Biotechnology, Bioinformatics, Healthcare IT, Machine learning & AI, and Information security.

Product overview

Two Bear Capital is a venture capital firm, not a product company. It does not offer a unified product platform or software-as-a-service offering. The firm invests in founders building companies at the intersection of life sciences and technology, providing early-stage capital and mentorship to portfolio companies. Two Bear Capital's focus areas include biotechnology, bioinformatics, healthcare IT, machine learning & AI, and information security. The firm's activities are centered on investment management, portfolio company support, and capital formation rather than product development or commercialization.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • $67B+ combined market value from 54 investments at Sequoia
  • +1 more outcomes

Companies that use Two Bear Capital

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Two Bear Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Two Bear Capital partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core, moderate and minor.

  • AWS MarketplacecoreChannel Partner/ Reseller/ DistributorQuProtect platform is available for purchase through AWS Marketplace, making it accessible to AWS customers seeking post-quantum cryptography solutions.
  • DellmoderateChannel Partner/ Reseller/ DistributorQuSecure's QuProtect platform is available through Dell's sales channel.
  • CiscomoderateChannel Partner/ Reseller/ DistributorQuSecure's QuProtect platform is available through Cisco's sales channel.
  • CarahsoftmoderateChannel Partner/ Reseller/ DistributorQuSecure's QuProtect platform is available through Carahsoft for government customers.
  • NuvOx TherapeuticsminorStrategic or Co-development PartnerFYR Bio and NuvOx Therapeutics were jointly awarded an NCI Direct-to-Phase-II SBIR Grant to advance liquid-biopsy collaboration in a Phase IIb glioblastoma trial.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Two Bear Capital competitors and assessment

Company assessment

Direct peers

  • Lux Capital: Early-stage venture firm investing at the intersection of science and technology, with a similar thesis around biotech, AI, and frontier-tech bets. Directly comparable in check size, sector focus, and stage (Seed to Series B) to Two Bear Capital.
  • ARCH Venture Partners: Early-stage venture firm heavily focused on life sciences, biotech, and deep-tech companies out of university and research labs. Highly comparable to Two Bear Capital's biotech and bioinformatics emphasis, including Nobel-tier scientific advisors.
  • Khosla Ventures: Early-stage venture firm investing across technology and life sciences with high-conviction, founder-led approach. Directly comparable in sector breadth (AI, biotech, cybersecurity) and willingness to lead Seed/Series A rounds.
  • DCVC (Data Collective): Science- and engineering-led venture firm investing in early-stage companies at the intersection of deep tech, AI, and life sciences. Closely comparable thesis and stage focus to Two Bear Capital.
  • Founders Fund: Early-stage venture firm focused on transformative technologies across biotech, AI, and frontier software. Comparable in founder-pedigree-driven brand, willingness to lead rounds, and high-conviction sector bets.
  • 8VC: Early-stage venture firm investing in technology, life sciences, and logistics with an operator-heavy team. Comparable in check size, sector breadth, and emphasis on operational support to founders.
  • Section32: Venture firm investing in early-stage companies at the intersection of technology and healthcare/life sciences. Highly comparable thesis given Two Bear Capital's biotech and healthcare IT focus, and similar fund scale.

Broad incumbents

  • General Catalyst: Multi-stage venture firm with broad sector coverage including life sciences, security, and AI. Larger and more diversified than Two Bear Capital but invests in overlapping categories and at comparable early stages.
  • Andreessen Horowitz (a16z): Mega-fund venture firm with dedicated bio/health and security practices. Operates at significantly larger fund scale than Two Bear Capital but overlaps heavily in thesis areas like AI, cybersecurity, and biotech.
  • NEA (New Enterprise Associates): Large multi-stage venture firm with deep life sciences and technology franchises. Comparable in sector breadth but materially larger fund size, providing context for Two Bear Capital's relative scale within the early-stage VC landscape.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Two Bear Capital social profiles

Digital presence

Two Bear Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Two Bear Capital leadership team

Management profile

Number of profiles

Profiles17 records

Two Bear Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Two Bear Capital M&A and investment

M&A and investment

M&A

Investments35 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Two Bear Capital

What does Two Bear Capital do?

Two Bear Capital is a private venture capital firm that invests in early-stage (Seed to Series B) technology and life sciences companies headquartered in the US and Canada. The firm typically leads or co-leads funding rounds with initial checks of $3-10M, providing portfolio companies with strategic guidance, operational support, network access, and active board participation across five focus sectors: Biotechnology, Bioinformatics, Healthcare IT, Machine learning & AI, and Information security.

Is Two Bear Capital a public or private company?

Two Bear Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Two Bear Capital founded?

Two Bear Capital was founded in 2019. It employs 11 to 50 people.

Where is Two Bear Capital based?

Two Bear Capital is headquartered in Whitefish, United States, in the North America region.

How does Two Bear Capital make money?

Two revenue lines are on record. Management Fees are the primary driver. The others are carried Interest.

Who are Two Bear Capital's main competitors?

Direct peers on record are Lux Capital, ARCH Venture Partners, Khosla Ventures, DCVC (Data Collective), Founders Fund, 8VC and Section32. Broad incumbents are General Catalyst, Andreessen Horowitz (a16z) and NEA (New Enterprise Associates).

Does Two Bear Capital have an API?

No public API is recorded for Two Bear Capital.

What industry is Two Bear Capital in?

Two Bear Capital's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B), with a secondary code of FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 52394 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
WikipediaSimple English Wikipedia, the free encyclopediaQuSecure, a U.S. cybersecurity company specializing in post-quantum cryptography, has raised $28 million in a Series A funding round in February 2025, led by Two Bear Capital with participation from Accenture Ventures, and appointed Rebecca Krauthamer as chief executive officer. The company also launched QuProtect R3, a production-ready post-quantum cryptography platform, in September 2025. QuSecure has previously demonstrated multi-orbit data communications using post-quantum cryptography with Accenture in March 2023 and achieved SOC 1 and SOC 2 Type II compliance in May 2024.AETOSWireBinarly Announces Leadership Transition as Enterprise Demand Accelerates for Supply-Chain SecurityBinarly announced a leadership transition, with founder Alex Matrosov joining the board and Gwenyth Castro appointed CEO to scale enterprise growth. The company's Transparency Platform, trusted by Meta and Dell, aims to address supply-chain security as AI accelerates software development.PR NewswireRainfall Health Announces $15M Series A Investment to Support Hospitals Impacted by New CMS Revenue OpportunityRainfall Health, an AI-driven compliance and reimbursement platform for hospitals, announced the close of a $15 million Series A funding round led by Two Bear Capital on February 18, 2026. The company plans to use the investment to build out its AI and customer support teams to help hospitals comply with the Centers for Medicare and Medicaid Services' Transforming Episode Accountability Model (TEAM), which launched on January 1, 2026 and offers hospitals up to 20% increased revenue for meeting quality metrics on five high-spend surgical procedures. The funding positions Rainfall Health to accelerate implementations as hospitals across the country seek to navigate the new value-based reimbursement era.FinSMEsRainfall Health Raises $15M in Series A FundingRainfall Health, a San Francisco-based provider of an AI-driven compliance and reimbursement platform for hospitals and medical groups, has raised $15 million in Series A funding. The round was led by Two Bear Capital and will support the company's expansion of operations and product development efforts. The company helps healthcare organizations navigate value-based care models, including CMS's TEAM model scheduled for launch on January 1, 2026.MorningstarRainfall Health Announces $15M Series A Investment to Support Hospitals Impacted by New CMS Revenue OpportunityRainfall Health, an AI-driven compliance and reimbursement platform for hospitals, has closed a $15 million Series A funding round led by Two Bear Capital. The investment will fund expansion of AI and customer support teams to help hospitals comply with the new CMS Transforming Episode Accountability Model (TEAM), which launched January 1, 2026 and offers hospitals up to 20% increased revenue for meeting quality metrics on five high-spend surgical procedures.Venture Capital Access OnlineInimmune raises $22 Million in Series A Funding Led by Two Bear CapitalInimmune, a Missoula-based biotechnology company, raised $22 million in its first Series A funding round led by Two Bear Capital. The company intends to use the capital to advance late-stage pre-clinical drug candidates in oncology and allergy through Phase I human clinical trials. This investment supports Inimmune's ongoing efforts to develop immune therapies and vaccines for various diseases.The SaaS NewsRevenium Raises $13.5 Million Seed RoundRevenium, a Herndon, Virginia-based financial intelligence platform for managing and optimizing AI spend, has raised $13.5 million in a Seed funding round. The round was led by Two Bear Capital with participation from WestWave Capital. The company plans to use the funding to support product development, market expansion, hiring, and adoption of its platform for managing AI economics.VentureburnRevenium Raises $13.5M to Build the System of Record for AI EconomicsRevenium closed a $13.5 million seed round led by Two Bear Capital with participation from WestWave Capital to build what it calls a system of record for AI economics. The platform provides real-time telemetry, anomaly detection, and cost governance tools that connect AI usage to financial outcomes, helping organizations track spend across models and agents. The funding will accelerate product development, expand go-to-market efforts, and support hiring for engineering and customer success teams as the company targets enterprises adopting multi-model AI stacks.Venture Capital Access OnlineRevenium Closes $13.5 Million Seed Round Funding Led by Two Bear Capital with Participation from WestWave CapitalRevenium, a financial intelligence platform for managing AI spend, has closed a $13.5 million seed round funding led by Two Bear Capital with participation from WestWave Capital. The funding will fuel product development, expand market reach, and accelerate the company's mission to deliver full-stack economic intelligence for AI operations. Concurrent with the announcement, Revenium debuted a new website and digital resources as part of its go-to-market expansion.citybizRevenium Raises $13.5M Seed Round Led by Two Bear CapitalRevenium, a financial intelligence platform for managing and optimizing AI spend, closed a $13.5 million seed round led by Two Bear Capital with participation from WestWave Capital. The funding will accelerate product development, expand market reach, and support the company's mission to provide full-stack economic intelligence for the AI ecosystem. Concurrently, Revenium launched a new website and is actively hiring across engineering, product management, and customer success to drive adoption of its platform.